Brief: Ampio Enters Into Collaborative Research Agreements
10/12/2020 14:35
Dec 10 (Reuters) - Ampio Pharmaceuticals Inc AMPE.A :
* AMPIO ENTERS INTO COLLABORATIVE RESEARCH AGREEMENTS TO
EXPLORE
ADDITIONAL CLINICAL INDICATIONS FOR ITS IMMUNOMODULATORY DRUG,
AMPION
Source text for Eikon: ID:nPn6Gs6XVa
Further company coverage: AMPE.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Ampio Pharmaceuticals
See all newsBrief: Ampio Announces Voluntary Delisting And SEC Deregistration
Brief: Ampio Provides Update On Results From Pre-IND Enabling Studies
Brief: Ampio Selects Ascendia Pharmaceuticals, Inc. To Provide CDMO Services To Support Clinical Development Of OA-201
Brief: Ampio Pharmaceuticals Announces Reverse Stock Split
Brief: Ampio Pharmaceuticals Inc - Holds Approximately $1.25 Million In A Deposit Account At Silicon Valley Bank